The use of plasmapheresis in pregnancy with antenatal prediction of a serious hemolytic disease due to Rh immunization.
Plasmapheresis was performed on twelve women with antenatal prediction of severe hemolytic disease due to Rh or Kell alloimmunization. No complications in mothers or newborn infants due to this treatment were observed neither during pregnancy nor in post-deliver period. In two patients the increase of antibody titer was not prevented. In four cases the fetus was not saved.
D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005260:Female; D005313:Fetal Death / Q000517:prevention & control; D006801:Humans; D007231:Infant, Newborn; D007518:Isoantibodies / Q000032:analysis; D007751:Labor, Induced; D007752:Obstetric Labor, Premature; D010956:Plasmapheresis; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System
D007518:Isoantibodies; D012204:Rh-Hr Blood-Group System